Medtronic plc, MDT is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, Medtronic plc, MDT has a market cap of 118777.81. Since its IPO date on the 12/31/1981, Medtronic plc, MDT performance year to date is 12.88%. Today Medtronic plc, MDT has gained 0.01%, with a current price of 85.96.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 85.70%. The management of the company have seen the company have a payout ratio of 60.40%. Return of assets are at 3.60%, with return on investment at 5.40%.
In terms of debt levels and profit levels, Medtronic plc, MDT is seeing a long-term debt/equity of 0.59. While Total debt/equity is 0.63. With a profit margin of 12.70%, this is combined with a gross margin of 68.90%, and operating margin of 18.50%. Medtronic plc ability to meet debt levels, with a current ratio of 3, while the quick ratio is 2.5.
For the last year Medtronic plc, MDT has seen a EPS growth of 2.90%. A performance for the year of 20.51%. The 52-week high is -3.71%, and the 52-week low is 24.50%. The average volume for Medtronic plc, MDT is 3170600.
With a target price of 94.68, can Medtronic plc, MDT reach this target? Looking at the value indicators of Medtronic plc, MDT. Medtronic plc has a P/E of 33.41 and a forward P/E of 16.59. Perhaps the more useful indicator than P/E, is PEG which has a value of 4.19. Medtronic plc also has a P/S and a P/B of 4.13 and 2.35 respectively. For P/cash, Medtronic plc has a value of 9.27, while it is 45.68 for P/free cash flow.
At the current price of 85.96, Medtronic plc has a dividend yield of 2.00%. We see a return on equity of 7.10%.
Looking more long-term Medtronic plc, is projected to get an EPS growth for the next five years of 7.98%. In the short-term an EPS growth of 11.25% in the next year is forecasted. This is after a EPS growth of 2.90% for this year and for the last five years a -2.60% growth has been seen.